The Benephit® PVMini Infusion System, an additional product offering from the Benephit PV Infusion System, allows for bilateral infusion to the kidneys in patients with smaller vascular anatomies.  The Benephit PVMini Infusion System, is an FDA 510(k) cleared, CE Marked, novel, proprietary selective infusion catheter system designed for implementing Targeted Renal Therapy (TRT™) - the direct delivery of physician-specified medications and other therapeutic agents to the kidneys via the renal arteries.

The Benephit PVMini Infusion System is designed for patients with smaller vascular anatomies who may benefit from TRT in conjunction with endovascular interventional and diagnostic procedures. The system has also been used for stand-alone percutaneous therapy in patients undergoing complex surgical procedures.

Using the same general platform as the Benephit PV Infusion System, the Benephit PVMini Infusion System’s small profile allows facile introduction through a second arterial access site during a planned endovascular procedure or through a single access site during surgical procedures.

The Benephit PVMini Infusion System consists of two components:

1. The PVMini Bifurcated Infusion Catheter

2. The 5 Fr Introducer Sheath

The PVMini Bifurcated Infusion Catheter features two identical branches to allow for the simultaneous infusion of physician-specified medications and other therapeutic agents directly to both renal arteries. These branches can be placed in the arteries easily, rapidly and safely with minimal radiocontrast media, and without the use of guide wires.

The introducer sheath for the Benephit PVMini System provides renal access through a single site, allowing a retrograde approach through the femoral artery.